Featured Posts
Recent Posts
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Classic
  • Twitter Classic
  • Google Classic

Jeffrey Friedland to Speak at the Emerging Manager Forum at the Fairmont San Francisco on November 9th on "Cannabis as an Alternative Investment"

November 3, 2017

 

The Emerging Manager Forum will enable attendees to meet with active emerging manager investors; hear from successful emerging fund managers and network with over 150 attendees.  

The Emerging Manager Forum is being chaired by Jay Gould, a partner, and co- chair of the financial services corporate practice at  Winston & Strawn.

As a speaker at the Emerging Manager Forum, Jeffrey Friedland will join the special guest speaker, Antonio Villaraigosa, former mayor of Los Angeles and 2018 California gubernatorial candidate. 

The title of Jeffrey Friedland's speech is: "Cannabis as an Alternative Investment, Headwinds as January 1, 2018 Approaches." He will discuss:

  • Why is cannabis so misunderstood?

  • What are the legal issues regarding investing in the cannabis industry?

  • How do cannabis participants obtain banking and other financial services?

  • Is there a safe harbor regarding investing in the cannabis industry so that it's 100 percent federally legal?

  • What are the 14 sub-sectors of investments in the cannabis industry?

Joining Jeffrey Friedland and Antonio Villaraigosa as speakers will be:

  • Chris Ainsworth, Senior Portfolio Manager, U.S. Trust

  • Brian Altenburg, Managing Partner & co-founder, HIghmore

  • Richard Beleutz, Managing Partner, Alternative Investment Research

  • Vaughn Blake, Managing Partner, Autochrome Axis LP

  • Brent Carey, Managing Partner, Indigo Global Advisors

  • Lewis Chong, Partner, Harneys

  • Howard Coleman, Chief Investment Officer, Coldstream Wealth Management

  • Jean-Francois Crouisillat, Managing Director, Franklin Templeton Investments

  • Richard de Silva,  Managing Partner, Lateral Investment Management

  • Sahil Desai, Vice President & Associate General Counsel, First Republic Bank

  • Matthew Donaldson, Managing Director, Castle Hill Capital Patners

  • Sayan Gomel, Managing Director & Head of Corporate Development, Silicon Valley Bank

  • Daniel Hart, Managing Director, Cortland Fund Services

  • Bryan Johnson, Managing Partner, Johnson & Co.

  • Eli Kent, Managing Partner, Moody Aldrich Partners

  • Beth Kramer, Partner, Winston & Strawn

  • Phillip Larrieu, Investment Officer, CalSTRS

  • JP Marra, CEO, Blue Elephant Capital Management

  • Matei Odebescu, Director, EisnerAmper

  • Neeraj Rama, Chief Investment Officer, CBCC

  • Jet Theriac, Chief Investment Officer, Lanternback Capital

Click Here for the Emerging Manager Forum Website
 

If you are starting up a new fund, are an emerging managerwith less than $500 million of assets under management, or a fund investor, you may be entitled to attend this event for free.

Please contact anne.thormann@KNect365.com for further details.
 

About Jeffrey Friedland

 

Jeffrey Friedland first traveled to China in 1988, opened an office for Friedland Capital in China in 2003 and continues to make frequent visits to the Asia-Pacific region and Latin America.  He is an author, speaker and thought leader on emerging and frontier markets, the global economy, and the global cannabis industry.  His first book, was "All Roads Lead to China - An Investor Road Map to the World's Fastest Growing Economy."  Mr. Friedland's latest book, Marijuana: The World's Most Misunderstood Plant was published in late 2015. Both books are available at Amazon.​

 

He is CEO of INTIVA Inc., a multi-faceted company in the worldwide legal cannabis industry. INTIVA established businesses and made investments in the cannabis industry in California, Colorado, and Canada.  INTIVA has invested in Canadian cannabis growers licensed as “Licensed Producers” under Health Canada regulations and has an investment in the cannabis industry in Israel.

 

He is also CEO of INTIVA BioPharma, which is developing cannabinoid-based drugs under U.S. Food & Drug Administration protocols.

 

He is also a board member of Israel-based CannRX, a company focused on cannabis-based pharmaceutical development and is an advisor to Fundanna, which has recently launched a crowdfunding site for the cannabis industry.

 

Mr. Friedland has been the chief executive officer and a director of a NASDAQ listed financial services company, a director of a New York Stock Exchange-listed company with all of its business operations in China, and the chairman of the supervisory board of a Hong Kong-based company with a stock market listing on the European Union Regulated Market of the Frankfurt Stock Exchange.

 

Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbes.

 

Mr. Friedland has been a frequent speaker at conferences and events throughout North America, Europe and Asia, including speeches to individual and institutional investors on investments, emerging markets, and the global cannabis industry.

 

Jeffrey Friedland Website: www.jeffreyfriedland.com

 

Jeffrey Friedland’s Articles and Videos: www.jeffreyfriedland.com/blog

Please reload

FOLLOW ME

  • Facebook Classic
  • Twitter Classic

© 2018 Jeffrey Friedland - All Rights Reserved